Quantum computing isn't as far away as it seems. Every month, there seems to be a new breakthrough with the technology, and it makes the possibility of commercially viable quantum computing inch closer and closer. Most of the money in the quantum computing space will be made years before it becomes widely available, so it's imperative that investors devote a small amount of their portfolio to this...
Quantum computing isn't as far away as it seems. Every month, there seems to be a new breakthrough with the technology, and it makes the possibility of commercially viable quantum computing inch closer and closer. Most of the money in the quantum computing space will be made years before it becomes widely available, so it's imperative that investors devote a small amount of their portfolio to this rising industry. Three stocks I'm bullish on in the quantum sector are Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) , IonQ (NYSE: IONQ) , and Nvidia (NASDAQ: NVDA) . Each of them represents a unique way to invest in quantum computing, and all have major upside. Image source: Getty Images. Continue reading
matdesign24/iStock via Getty Images Merck ( MRK ) and Gilead Sciences ( GILD ) said that topline results from a pair of phase 3 trials of a combination pill containing the former's islatravir and the latter's lenacapavir met their primary endpoint. The two studies, ISLEND-1 and ISLEND-2 trial, are testing the once-weekly treatment in HIV virologically suppressed individuals who switched from Bikta...
matdesign24/iStock via Getty Images Merck ( MRK ) and Gilead Sciences ( GILD ) said that topline results from a pair of phase 3 trials of a combination pill containing the former's islatravir and the latter's lenacapavir met their primary endpoint. The two studies, ISLEND-1 and ISLEND-2 trial, are testing the once-weekly treatment in HIV virologically suppressed individuals who switched from Biktarvy (bictegravir/emtricitabine/tenofovir) (ISLEND-1) or standard of care antiretroviral regimens (ISLEND-2). The primary endpoint for both trials is the number of patients with HIV-1 RNA ≥ 50 copies/mL at Week 48. Also, islatravir/lenacapavir was found to be non-inferior ro Biktarvy and standard oral antiretroviral therapies. Islatravir, a nucleoside reverse transcriptase translocation inhibitor, is sold by Merck as a fixed-dose combination with doravirine as Idvynso, while lenacapavir is marketed by Gilead as Sunlenca. Separately, the two companies announced that they are ending the phase 3 KEYNOTE-D46/EVOKE-03 study of Gilead's Trodelvy (sacituzumab govitecan) with Merck's Keytruda (pembrolizumab) in first-line metastatic non-small cell lung cancer based on the recommendation of a Data Monitoring Committee. More on Gilead Sciences, Merck Merck & Co.: Why The Market Is Right To Start Buying Into Post-Keytruda Promise Merck & Co., Inc. (MRK) Discusses Oncology Strategy and Program Update With Focus on Clinical Progress and Pipeline Diversification - Slideshow Merck & Co., Inc. (MRK) Presents at Jefferies Global Healthcare Conference 2026 Transcript HHS indicates skepticism on international cancer risk assessments Gilead, Lakefront complete Ouro Medicines acquisition
Omar Artan, who was set to be the first Somalian to referee at the World Cup finals, is dropped from the list of officials after he was denied entry to the United States.
Omar Artan, who was set to be the first Somalian to referee at the World Cup finals, is dropped from the list of officials after he was denied entry to the United States.
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer internet industry, including Alphabet (NASDAQ:GOOGL) and its peers.
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer internet industry, including Alphabet (NASDAQ:GOOGL) and its peers.
OpenAI filed confidentially for an IPO with the SEC, working with Goldman Sachs Group and Morgan Stanley on a potential listing. Romaine Bostick reports on "Balance of Power." (Source: Bloomberg)
OpenAI filed confidentially for an IPO with the SEC, working with Goldman Sachs Group and Morgan Stanley on a potential listing. Romaine Bostick reports on "Balance of Power." (Source: Bloomberg)
On The Kavanaugh Anniversary, Democratic Leaders Swap Me Too For Maine Authored by Jonathan Turley, ...on the eighth anniversary of the Kavanaugh nomination. It now appears that there are some women who are not to be believed... when the Senate may be in the balance.. “It’s clear the fix is in.” Those words from Sen. Elizabeth Warren (D-Mass.). came with her vote against confirming Brett Kavanaugh...
On The Kavanaugh Anniversary, Democratic Leaders Swap Me Too For Maine Authored by Jonathan Turley, ...on the eighth anniversary of the Kavanaugh nomination. It now appears that there are some women who are not to be believed... when the Senate may be in the balance.. “It’s clear the fix is in.” Those words from Sen. Elizabeth Warren (D-Mass.). came with her vote against confirming Brett Kavanaugh to the Supreme Court. Warren was outraged that her fellow senators refused to believe a woman who came forward with a decades-old allegation against Kavanaugh that lacked any corroboration. It now appears that Kavanaugh’s former accusers are making the case that he was treated unjustly at their hands. At least they are now willing to swap “Me Too” for Maine. Warren’s words were part of a mantra from Democratic members that either you believe women about sexual harassment and assault, or you are enabling abusers. It was almost exactly eight years ago, in July 2018, that President Trump nominated Kavanaugh to fill the seat of retiring Associate Justice Anthony Kennedy. Kavanaugh, who was at first a very uncontroversial nominee, suddenly became the target of a well-financed, well-orchestrated campaign that would continue to resonate in that fall’s election campaigns. At the time, your failure to accept the word of Christine Blasey Ford that Kavanaugh had assaulted her in high school was just proof that you and the system were sexist. Long after the Senate confirmed Kavanaugh, the left continued to claim that his presence on the Supreme Court “rests on a mountain of misogyny.” In Ms. Magazine, actress Kathleen Turner reminded people that not believing women was furthering misogyny: “Survivors who come forward break the rules of silence a sexist society demands, and society expects them to pay a price.” If you recall, the lack of evidence led to the Senate Judiciary Committee combing through Kavanaugh’s personal calendars. Denials that such a thing had ever happened, coming fro...
Welcome back to Canada Daily, the newsletter on business, economics and politics from Vancouver to Montreal and beyond. If this was forwarded to you, sign up . The size of the artificial intelligence boom is truly mind-bending sometimes. Whether it’s Alphabet’s $85 billion equity sale or Anthropic’s nearly $1 trillion valuation, the numbers are usually enormous, and often record-breaking. Add anot...
Welcome back to Canada Daily, the newsletter on business, economics and politics from Vancouver to Montreal and beyond. If this was forwarded to you, sign up . The size of the artificial intelligence boom is truly mind-bending sometimes. Whether it’s Alphabet’s $85 billion equity sale or Anthropic’s nearly $1 trillion valuation, the numbers are usually enormous, and often record-breaking. Add another one to the list: Amazon.com became the second hyperscaler to tap the Canadian-dollar bond market in the past two months with a record-shattering C$14 billion ($10 billion) debt sale. The five-part corporate bond sale was the largest ever such deal in Canada, eclipsing the previous record held by Alphabet, the parent of Google, which raised a mere C$8.5 billion a little more than a month ago. Investors were all over it, eager to lend. Amazon’s deal drew orders about twice the size of the available debt, according to people familiar with the matter, asking not to be identified discussing private matters. The longest portion of the deal, a 30-year bond, had some 125 buyers, they said. The size of Amazon’s borrowing speaks to the ambitions of its cloud business and the frenzy for computing power to serve AI applications. Amazon is expected to spend around $200 billion this year, which explains its need to borrow as much as possible from wherever it can. Canadian investment grade corporate spreads widened by two to three basis points after the deluge of Amazon debt, according to people familiar with the market. In other words, it temporarily drove risk premiums higher for the whole market. Amazon is now one of the 10 largest issuers in the Canadian investment-grade corporate bond market, according to a Bloomberg index . That means with a single deal, Amazon is now a bigger part of Canada’s debt market than National Bank of Canada and Telus, two companies that date back more than a century. Also in this newsletter: Buying shares in private companies . The stock market is wavi...
OpenAI on Monday checked off a preliminary step in the IPO race that it and rival Anthropic have been competing in for the better part of a year: The company announced it has confidentially submitted a Form S-1 with the US Securities and Exchange Commission, following Anthropic's decision to do the same on June 1st. The confidential filing means that certain details normally available through the ...
OpenAI on Monday checked off a preliminary step in the IPO race that it and rival Anthropic have been competing in for the better part of a year: The company announced it has confidentially submitted a Form S-1 with the US Securities and Exchange Commission, following Anthropic's decision to do the same on June 1st. The confidential filing means that certain details normally available through the form - such as executive compensation figures, potential risks to a company's business, and more financials - aren't yet public. As of Anthropic's most recent fundraise, it's being called the world's most valuable startup, with a post-money valu … Read the full story at The Verge.
Chip Somodevilla/Getty Images News OpenAI ( OPENAI ) outlined a new goal where it hopes to deliver a personal AGI, or artificial general intelligence, to every human on the planet. It was one of three new goals the Microsoft-backed ( MSFT ) company revealed today in a blog post by OpenAI CEO Sam Altman and its chief scientist Jakub Pachocki. "Give everyone on Earth a personal AGI , empowering them...
Chip Somodevilla/Getty Images News OpenAI ( OPENAI ) outlined a new goal where it hopes to deliver a personal AGI, or artificial general intelligence, to every human on the planet. It was one of three new goals the Microsoft-backed ( MSFT ) company revealed today in a blog post by OpenAI CEO Sam Altman and its chief scientist Jakub Pachocki. "Give everyone on Earth a personal AGI , empowering them to benefit from one of humanity's most transformative technologies in whatever way they choose," they said. The other main goals include building an automated AI researcher and accelerating the economy. They also echoed a sentiment made clear in a blog post last week by rival Anthropic ( ANTHRO ). Anthropic plans to organize meetings with policymakers, researchers, and other AI companies to discuss how to prevent AI from becoming a possible threat to humanity. "We are optimistic about AI because we believe it can expand human capability and prosperity," wrote Altman and Pachocki. "But we are also clear-eyed about the risks. Powerful systems must remain safe, aligned with human intent, and subject to human control." They called for the creation of an international organization to help regulate AI. "As frontier AI development continues, we expect national and global coordination to become more important," they added. "We have long believed there should ultimately be an international organization that helps coordinate leading AI efforts to reduce catastrophic risk. Cooperation and shared safety standards are an important part of the path forward, especially because the incentives around commercial and national competition are hard to escape." More on OpenAI, Anthropic and Microsoft Microsoft: The $37 Billion AI Question Investors Can't Ignore Microsoft: Future Global Cognitive Utility Microsoft Stock Rejected A Key Resistance Level. What's Next US acquiring voluntary equity stakes in AI firms appears manageable: Wedbush Microsoft in focus as NHS rolls out Microsoft 365 Copilo...